Most men over 50 will develop an enlarged prostate. Also called benign prostatic hyperplasia, this bothersome condition makes it hard to urinate and can eventually lead to other problems, such as ...

Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) symptoms receiving pharmacologic therapy for benign prostatic ...

Discover a study where findings demonstrated that the novel drug-injectable urethral catheter set increased patient ...

A HALF-HOUR scan could help bladder cancer patients be treated almost twice as fast, a groundbreaking study has found. Using ...

Discover a recent study that introduced a novel approach combining preoperative 3D printing with intraoperative ...

These surgeons have extra training and expertise in reconstructive pelvic bladder surgery. And every member of your surgical ... Kidney stones are a common health concern. About 11% of men and 9% of ...

Patients with suspected new bladder cancer were randomly assigned 1:1 to transurethral resection of bladder tumor or ...

Patients were given either standard chemotherapy (cisplatin and gemcitabine) and surgery (530 ... overall in the UK for men and women. “Mutations to the DNA of bladder cells cause the cancer ...

Bladder cancer is one of the most common malignant tumors in urinary system, and the treatment faces huge challenges.

A combination therapy of two drugs — a statin and a protein inhibitor — may help suppress the creation and growth of tumors ...